$90.99
0[0.00%]
At close: Apr 26
$90.99
0[0.00%]
PreMarket: 4:20PM EDT
Haemonetics
(NYSE:HAE)Latest News for Haemonetics Stock (NYSE:HAE)
Haemonetics Stock (NYSE: HAE)
Categories: All
Friday, April 12, 2024
Thursday, April 04, 2024
Tuesday, March 05, 2024
Tuesday, February 13, 2024
Thursday, February 08, 2024
- Haemonetics Expects Reported And Organic Sales Growth Of 10%-12% Versus 8%-10% Expected EarlierBenzinga Newsdesk - Feb 8, 2024, 6:08AM
- Haemonetics Q3 Adjusted EPS $1.04 Beats $0.94 Estimate, Sales $336.25M Beat $320.29M EstimateBenzinga Newsdesk - Feb 8, 2024, 6:02AM
- Earnings Scheduled For February 8, 2024Benzinga Insights - Feb 8, 2024, 4:43AM
Friday, November 03, 2023
Thursday, November 02, 2023
Tuesday, October 10, 2023
- 10 Health Care Stocks Whale Activity In Today's SessionBenzinga Insights - Oct 10, 2023, 1:35PM
- Haemonetics Has Agreed To Acquire Opsens For C$2.90 Per Share In An All-cash Transaction Representing A Fully Diluted Equity Value Of Approximately $253M At The Current Exchange RateBenzinga Newsdesk - Oct 10, 2023, 6:07AM
Wednesday, August 09, 2023
Tuesday, August 08, 2023
- Haemonetics Expects FY24 Revenue Growth Of 6%-9% Compared To 4%-7% Prior Guidance; Sees Adjusted EPS of $3.60-$3.90 Vs. Prior Guidance Of $3.45-$3.75 And Consensus Of $3.59Benzinga Newsdesk - Aug 8, 2023, 6:10AM
- Haemonetics Q1 Adjusted EPS $1.05 Beats $0.76 Estimate, Sales $311.33M Beat $297.92M EstimateBenzinga Newsdesk - Aug 8, 2023, 6:02AM
- Earnings Scheduled For August 8, 2023Benzinga Insights - Aug 8, 2023, 4:48AM
Monday, August 07, 2023
Friday, May 12, 2023
- Barrington Research Maintains Outperform on Haemonetics, Raises Price Target to $111Benzinga Newsdesk - May 12, 2023, 12:21PM
- Morgan Stanley Maintains Equal-Weight on Haemonetics, Raises Price Target to $96Benzinga Newsdesk - May 12, 2023, 7:43AM
- JMP Securities Maintains Market Outperform on Haemonetics, Raises Price Target to $115Benzinga Newsdesk - May 12, 2023, 6:14AM
Thursday, May 11, 2023
- Earnings Scheduled For May 11, 2023Benzinga Insights - May 11, 2023, 9:58AM
- Haemonetics Q4 Earnings Exceed Expectations On Volume And Price BenefitsNabaparna Bhattacharya - May 11, 2023, 9:26AM
- Recap: Haemonetics Q4 EarningsBenzinga Insights - May 11, 2023, 6:20AM
- Haemonetics Expects FY24 Revenue Growth Of 4%-7%, And Organic Growth Of 5%-8%; Sees Adjusted EPS Of $3.45-$3.75 Vs. $3.4 EstimateBenzinga Newsdesk - May 11, 2023, 6:11AM
- Haemonetics Q4 EPS $0.77 Beats $0.70 Estimate, Sales $304.42M Beat $289.64M EstimateBenzinga Newsdesk - May 11, 2023, 6:06AM
Wednesday, February 08, 2023
- Morgan Stanley Maintains Equal-Weight on Haemonetics, Raises Price Target to $88Benzinga Newsdesk - Feb 8, 2023, 10:43AM
- Citigroup Maintains Neutral on Haemonetics, Raises Price Target to $95Benzinga Newsdesk - Feb 8, 2023, 10:00AM
- Looking Into Haemonetics's Return On Capital EmployedBenzinga Insights - Feb 8, 2023, 9:48AM
- Alphabet To Rally Over 20%? Here Are 10 Other Analyst Forecasts For WednesdayLisa Levin - Feb 8, 2023, 9:18AM
- Barrington Research Maintains Outperform on Haemonetics, Raises Price Target to $103Benzinga Newsdesk - Feb 8, 2023, 9:03AM
- Mizuho Maintains Buy on Haemonetics, Raises Price Target to $115Benzinga Newsdesk - Feb 8, 2023, 7:03AM
Tuesday, February 07, 2023
- Haemonetics Raises FY23 Adj EPS Outlook from $2.70 - $3.00 to $2.90 - $3.00 Vs. $2.79 Est.Benzinga Newsdesk - Feb 7, 2023, 6:12AM
- Haemonetics Raises FY23 Sales Growth Guidance From 15% - 18% to 18% - 20%Benzinga Newsdesk - Feb 7, 2023, 6:10AM
- Haemonetics Q3 Adj EPS $0.85 Beats $0.80 Estimate, Sales $305.30M Beat $300.47M EstimateBenzinga Newsdesk - Feb 7, 2023, 6:07AM
- Earnings Scheduled For February 7, 2023Benzinga Insights - Feb 7, 2023, 5:17AM
Monday, February 06, 2023
Wednesday, February 01, 2023
Tuesday, January 24, 2023
Friday, January 06, 2023
Monday, December 12, 2022
Thursday, December 01, 2022
Tuesday, November 08, 2022
- Analysts Take Bullish Stance On Haemonetics, Cites Plasma Momentum As CatalystVandana Singh - Nov 8, 2022, 2:37PM
- Barrington Research Maintains Outperform on Haemonetics, Raises Price Target to $94Benzinga Newsdesk - Nov 8, 2022, 9:27AM
- Morgan Stanley Maintains Equal-Weight on Haemonetics, Raises Price Target to $90Benzinga Newsdesk - Nov 8, 2022, 9:12AM
- Expert Ratings for HaemoneticsBenzinga Insights - Nov 8, 2022, 8:59AM